Cargando…

Reproductive Factors and Colorectal Cancer Risk: A Population-Based Case-Control Study

BACKGROUND: Hormone-replacement therapy (HRT) is associated with lower colorectal cancer (CRC) risk among postmenopausal women. However, little is known about the effects of lifetime exposure of women to varying levels of estrogen and progesterone through reproductive factors such as parity, use of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amitay, Efrat L, Niedermaier, Tobias, Alwers, Elizabeth, Chang-Claude, Jenny, Hoffmeister, Michael, Brenner, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251386/ https://www.ncbi.nlm.nih.gov/pubmed/35642982 http://dx.doi.org/10.1093/jncics/pkac042

Ejemplares similares

Risk Factors of Inadequate Bowel Preparation for Screening Colonoscopy
por: Amitay, Efrat L., et al.
Publicado: (2021)

A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment
por: Niedermaier, Tobias, et al.
Publicado: (2023)

Smoking, alcohol consumption and colorectal cancer risk by molecular pathological subtypes and pathways
por: Amitay, Efrat L., et al.
Publicado: (2020)

The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials
por: Gruner, Laura F., et al.
Publicado: (2021)

Impact of Inadequate Bowel Cleansing on Colonoscopic Findings in Routine Screening Practice
por: Niedermaier, Tobias, et al.
Publicado: (2020)

Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study
por: Alwers, Elizabeth, et al.
Publicado: (2022)

Response to neoadjuvant treatment among rectal cancer patients in a population-based cohort
por: Alwers, Elizabeth, et al.
Publicado: (2020)

Variation of Positive Predictive Values of Fecal Immunochemical Tests by Polygenic Risk Score in a Large Screening Cohort
por: Niedermaier, Tobias, et al.
Publicado: (2022)

Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening
por: Gies, Anton, et al.
Publicado: (2021)

Association of Overweight, Obesity, and Recent Weight Loss With Colorectal Cancer Risk
por: Mandic, Marko, et al.
Publicado: (2023)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

Fecal Immunochemical Tests Combined With Other Stool Tests for Colorectal Cancer and Advanced Adenoma Detection: A Systematic Review
por: Niedermaier, Tobias, et al.
Publicado: (2016)

Colorectal Cancer Risk by Genetic Variants in Populations With and Without Colonoscopy History
por: Guo, Feng, et al.
Publicado: (2021)

The underestimated impact of excess body weight on colorectal cancer risk: Evidence from the UK Biobank cohort
por: Safizadeh, Fatemeh, et al.
Publicado: (2023)

Impact of Reducing Intake of Red and Processed Meat on Colorectal Cancer Incidence in Germany 2020 to 2050—A Simulation Study
por: Niedermaier, Tobias, et al.
Publicado: (2023)

DNA Methylation-Based Estimates of Circulating Leukocyte Composition for Predicting Colorectal Cancer Survival: A Prospective Cohort Study
por: Gào, Xīn, et al.
Publicado: (2021)

Physical activity, polygenic risk score, and colorectal cancer risk
por: Chen, Xuechen, et al.
Publicado: (2022)

Is the association of overweight and obesity with colorectal cancer underestimated? An umbrella review of systematic reviews and meta-analyses
por: Mandic, Marko, et al.
Publicado: (2023)

Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy
por: Park, Hanla A., et al.
Publicado: (2022)

Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies
por: Heisser, Thomas, et al.
Publicado: (2023)

Smoking, Genetic Predisposition, and Colorectal Cancer Risk
por: Chen, Xuechen, et al.
Publicado: (2021)

Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score
por: Weigl, Korbinian, et al.
Publicado: (2018)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study
por: Rudolph, Anja, et al.
Publicado: (2014)

External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS
por: Alwers, Elizabeth, et al.
Publicado: (2019)

Accuracy of a fecal immunochemical test according to outside temperature and travel time
por: Niedermaier, Tobias, et al.
Publicado: (2018)

Survival of patients with symptom- and screening-detected colorectal cancer
por: Brenner, Hermann, et al.
Publicado: (2016)

Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population‐based study
por: Alwers, Elizabeth, et al.
Publicado: (2020)

Probiotic/Synbiotic Treatment and Postoperative Complications in Colorectal Cancer Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Amitay, Efrat L., et al.
Publicado: (2020)

Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis
por: Niedermaier, Tobias, et al.
Publicado: (2020)

Personalizing the Prediction of Colorectal Cancer Prognosis by Incorporating Comorbidities and Functional Status into Prognostic Nomograms
por: Boakye, Daniel, et al.
Publicado: (2019)

Red and Processed Meat Intake, Polygenic Risk Score, and Colorectal Cancer Risk
por: Chen, Xuechen, et al.
Publicado: (2022)

Assessment of a Serum Microrna Risk Score for Colorectal Cancer among Participants of Screening Colonoscopy at Various Stages of Colorectal Carcinogenesis
por: Raut, Janhavi R., et al.
Publicado: (2022)

Association of Polypharmacy with Colorectal Cancer Survival Among Older Patients
por: Chen, Li‐Ju, et al.
Publicado: (2021)

Whole blood DNA methylation aging markers predict colorectal cancer survival: a prospective cohort study
por: Gào, Xīn, et al.
Publicado: (2020)

Impact of tobacco control policies implementation on future lung cancer incidence in Europe: An international, population-based modeling study
por: Gredner, Thomas, et al.
Publicado: (2021)

No association of CpG island methylator phenotype and colorectal cancer survival: population-based study
por: Jia, Min, et al.
Publicado: (2016)

Treatment selection bias for chemotherapy persists in colorectal cancer patient cohort studies even in comprehensive propensity score analyses
por: Boakye, Daniel, et al.
Publicado: (2019)

Serum Concentration of Genistein, Luteolin and Colorectal Cancer Prognosis
por: Jiang, Ruijingfang, et al.
Publicado: (2019)

Physical activity and long-term fatigue among colorectal cancer survivors – a population-based prospective study
por: Eyl, Ruth Elisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_of4mqcqm8c1u7b4pq0k272i0bb